Stock Earnings

Question 1

What are Haemonetics Corp's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Haemonetics Corp has a total asset of $2,450, Net profit of $167

Question 2

What are the key financial ratios for HAE?

Accepted Answer

Haemonetics Corp's Current ratio is 1.5, has a Net margin is 12.27, sales per share of $26.8.

Question 3

How is Haemonetics Corp's revenue broken down by segment or geography?

Accepted Answer

Haemonetics Corp largest revenue segment is Plasma Products and Services, at a revenue of 563,734,000 in the most earnings release.For geography, United States is the primary market for Haemonetics Corp, at a revenue of 1,010,918,000.

Question 4

Is Haemonetics Corp profitable?

Accepted Answer

yes, according to the latest financial statements, Haemonetics Corp has a net profit of $167

Question 5

Does Haemonetics Corp have any liabilities?

Accepted Answer

yes, Haemonetics Corp has liability of 1,630

Question 6

How many outstanding shares for Haemonetics Corp?

Accepted Answer

Haemonetics Corp has a total outstanding shares of 48.21

Breakdown	TTM	03/29/2025	03/30/2024	04/01/2023	04/02/2022	04/03/2021
Revenue	1,346	1,360	1,309	1,168	993	870
Revenue Growth (YoY)	1%	4%	12%	18%	14%	-12%
Cost of Revenue	573	597	600	545	467	462
Gross Profit	772	763	708	622	525	407
Selling, General & Admin	414	408	411	372	331	269
Research & Development	64	61	52	49	46	31
Operating Expenses	529	518	495	454	425	333
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	210	212	151	141	63	72
Income Tax Expense	47	44	34	26	20	-6
Net Income	163	167	117	115	43	79
Net Income Growth	43%	43%	2%	167%	-46%	4%
Shares Outstanding (Diluted)	48.35	50.73	51.39	51.4	51.4	51.3
Shares Change (YoY)	-6%	-1%	0%	0%	0%	-1%
EPS (Diluted)	3.37	3.3	2.28	2.24	0.84	1.55
EPS Growth	51%	45%	2%	167%	-46%	5%
Free Cash Flow	160	121	115	162	75	71
Free Cash Flow Per Share	3.3	2.38	2.23	3.15	1.45	1.38
Gross Margin	57.35%	56.1%	54.08%	53.25%	52.87%	46.78%
Operating Margin	18.05%	18.01%	16.27%	14.38%	10.07%	8.39%
Profit Margin	12.1%	12.27%	8.93%	9.84%	4.33%	9.08%
Free Cash Flow Margin	11.88%	8.89%	8.78%	13.86%	7.55%	8.16%
EBITDA	358	360	310	261	197	157
EBITDA Margin	26.59%	26.47%	23.68%	22.34%	19.83%	18.04%
D&A For EBITDA	115	115	97	93	97	84
EBIT	243	245	213	168	100	73
EBIT Margin	18.05%	18.01%	16.27%	14.38%	10.07%	8.39%
Effective Tax Rate	22.38%	20.75%	22.51%	18.43%	31.74%	-8.33%

Haemonetics Corp (HAE) Price

HAE Stock Price Chart

HAE Income

Follow-Up Questions